Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism CDK12 inhibitors(cyclin dependent kinase 12 inhibitors), CDK13 inhibitors(CHED protein kinase inhibitors), PARP inhibitors(Poly (ADP-Ribose) polymerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 08 Apr 2024 | |
Neoplasms | Preclinical | JP | Chordia Therapeutics, Inc.Startup | 08 Apr 2024 |